Leukemia Research
Volume 25, Issue 12 , Pages 1095-1096 , December 2001

Refractory anemia with excess of blasts in transformation: a dying category?

Received 6 April 2001 ,Accepted 6 April 2001.

References 

  1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al.  Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982;51:189
  2. Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, et al.  Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood. 1989;74:395
  3. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079
  4. Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk. Res. 2000;24:983
  5. Seymour JF, Estey EH. The contribution of Auer rods to the classification and prognosis of myelodysplastic syndromes. Leuk. Lymph. 1995;17:79
  6. Germing U, Strupp C, Giagounidis AS, Meckenstock G, Aul C. RAEB-T: a heterogeneous entity?. Leuk. Res. 1999;23(Suppl 1):A169
  7. Vallespi T, Sanz G, Torrabadella M, Irriguible D, Sanz MA. Auer rods in myelodysplastic syndromes (MDS): presence and significance. Blood. 1990;76(Suppl 1):330a
  8. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al.  World Health Organization classification of neoplastic diseases of the hematotopoietic and lymphoid tissues: report of the clinical advisory committee meeting – Airlie House, Virginia, November. J. Clin. Oncol. 1997;17(1999):3835
  9. Bennett J. The World Health Organization (WHO) classification of the acute leukemias and the myelodysplastic syndromes. Intern. J. Hematol. 2000;72:131–133
  10. Morel P, Hebbar M, Lai JL. Cytogenetic analysis has a strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia. 1993;7:1315
  11. Toyama K, Ohyashiki K, Yoshida Y, Abe T, Asano S, Hirai H, et al.  Clinical implication of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia. 1993;7:499
  12. Ohyashiki K, Nishimaki J, Shoji N, Miyazawa K, Kimura Y, Ohysahiki JH. Re-evaluation of refractory anemia with excess blasts in transformation. Leuk Res. 2001;25:933–939

PII: S0145-2126(01)00080-7

Leukemia Research
Volume 25, Issue 12 , Pages 1095-1096 , December 2001

Article Tools